GENOMIC HEALTH INC

Q: Sep 30 2019

Q: Jun 30 2019

Q: Mar 31 2019

FY: Dec 31 2018

Q: Sep 30 2018

Q: Jun 30 2018

Q: Mar 31 2018

FY: Dec 31 2017

Q: Sep 30 2017

Q: Jun 30 2017

Q: Mar 31 2017

FY: Dec 31 2016

Q: Sep 30 2016

Q: Jun 30 2016

Q: Mar 31 2016

FY: Dec 31 2015

Q: Sep 30 2015

Q: Sep 30 2015

Q: Jun 30 2015

Q: Mar 31 2015

2.01,3.01,3.03,5.01,5.02,5.03,9.01

5.07,7.01,9.01

8.01

8.01

1.01,9.01

8.01,9.01

2.02,9.01

5.07

2.02,9.01

2.02,9.01

5.03,9.01

5.02

2.02,9.01

2.02,9.01

5.07

2.02,9.01

2.02,9.01

2.02,9.01

5.03,9.01

2.02,9.01

Certification of termination of registration of a class of securities (Section 12(g))

Notice of Effectiveness

Notice of Effectiveness

Notification of removal from listing and/or registration on a national securities exchange

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

No description available

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

none

Parker Geoffrey M.

FUCHS HENRY J

McEachron Kim

Leber Laura

GRAHAM GINGER L

Flannelly Barry P

Cohen Fred E

Popovits Kimberly J

Cole G Bradley

Shak Steven

Pla Frederic

Vaughn James J

Radford Jason W.

Hoof Torsten

none

none

EXACT SCIENCES CORP

Leber Laura

Vaughn James J

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

No description available

No description available

Annual Report Scanned (Paper)

No description available

Annual Report Scanned (Paper)

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC